TuisSUNPHARMA ā¢ NSE
add
Sun Pharmaceutical Industries Ltd
Vorige sluiting
ā¹1Ā 898,40
Dagwisseling
ā¹1Ā 915,25 - ā¹1Ā 959,30
Jaarwisseling
ā¹1Ā 068,35 - ā¹1Ā 959,30
Markkapitalisasie
4,68Ā bn INR
Gemiddelde volume
1,87Ā m
P/V-verhouding
44,90
Dividend-opbrengs
0,69%
PrimĆŖre beurs
NSE
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(INR) | Jun. 2024info | J/J-verandering |
---|---|---|
Inkomste | 126,53Ā mjd | 5,96% |
Bedryfskoste | 69,74Ā mjd | 7,23% |
Netto inkomste | 28,36Ā mjd | 40,20% |
Netto winsgrens | 22,41 | 32,29% |
Wins per aandeel | 11,80 | 24,37% |
EBITDA | 35,92Ā mjd | 10,02% |
Effektiewe belastingkoers | 16,18% | ā |
Balansstaat
Totale bates
Totale aanspreeklikheid
(INR) | Jun. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 190,90Ā mjd | 26,17% |
Totale bates | ā | ā |
Totale aanspreeklikheid | ā | ā |
Totale ekwiteit | 671,06Ā mjd | ā |
Uitstaande aandele | 2,40Ā mjd | ā |
Prys om te bespreek | 7,15 | ā |
Opbrengs op bates | ā | ā |
Opbrengs op kapitaal | 10,67% | ā |
Kontantvloei
Netto kontantverandering
(INR) | Jun. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | 28,36Ā mjd | 40,20% |
Kontant van bedrywe | ā | ā |
Kontant van beleggings | ā | ā |
Kontant van finansiering | ā | ā |
Netto kontantverandering | ā | ā |
Beskikbare kontantvloei | ā | ā |
Meer oor
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Gestig
1983
Hoofkwartier
Webwerf
Werknemers
43Ā 000